What does the future of next generation implantable drug delivery devices look like? Harry Moorman believes a CC concept breakthrough in smart, miniaturised active implant innovation offers significant opportunity for a market that is ripe for development and commercial growth…
As AI continues to impact every aspect of business, should your enterprise appoint a chief AI officer to navigate implementation and the changing compliance landscape? Dr Maya Dillon spoke to IT Pro “When AI ambitions demand strategic vision, responsible AI practices, and successful implementation, hiring a CAIO becomes a catalyst for transformative success.”
Our digital surgery team was out in force at the Hamlyn Symposium on Medical Robotics. In this article, VP of Digital Surgery Andrew Savarese reflects on the insights and analysis, and introduces key topics that characterise the deep tech opportunities that are unfolding…
CC’s findings in its report on the current and future state of smart cities in Japan have wider implications. As Jiahui Hermes explains, organisations intent on innovation in this space can benefit from exploring themes that are common to the challenges of smart infrastructure across a range of applications anywhere in the world…
One of the major questions to address when designing a new implantable medical device is how best to power it. Drawing on his extensive knowledge of the field, medical device development expert Neil Rosewell has identified the top six issues around smart implant power that developers need to bear in mind right now
Quantum technology commercial adoption will be gradual – but that doesn’t mean ambitious business leaders should adopt a wait and see approach.